Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

407
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

249
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

IN VITRO GENERATED HEPATOCYTE-LIKE CELLS: A NOVEL TOOL IN REGENERATIVE MEDICINE AND DRUG DISCOVERY (REVIEW ARTICLE)

Pages

  204-217

Abstract

 HEPATOCYTE-like cells (HLCs) are generated from either various human pluripotent stem cells (hPSCs) including induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), or direct cell conversion, mesenchymal stem cells as well as other stem cells like gestational tissues. They provide potential cell sources for biomedical applications. Liver transplantation is the gold standard treatment for the patients with end stage liver disease, but there are many obstacles limiting this process, like insufficient number of donated healthy livers. Meanwhile, the number of patients receiving a liver organ transplant for a better life is increasing. In this regard, HLCs may provide an adequate cell source to overcome these shortages. New molecular engineering approaches such as CRISPR/ Cas system applying in iPSCs technology provide the basic principles of gene correction for monogenic inherited metabolic liver diseases, as another application of HLCs. It has been shown that HLCs could replace primary human HEPATOCYTEs in DRUG DISCOVERY and hepatotoxicity tests. However, generation of fully functional HLCs is still a big challenge; several research groups have been trying to improve current differentiation protocols to achieve better HLCs according to morphology and function of cells. Large-scale generation of functional HLCs in bioreactors could make a new opportunity in producing enough HEPATOCYTEs for treating end-stage liver patients as well as other biomedical applications such as drug studies. In this review, regarding the biomedical value of HLCs, we focus on the current and efficient approaches for generating HEPATOCYTE-like cells in vitro and discuss about their applications in regenerative medicine and DRUG DISCOVERY.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    ZAKIKHAN, KOBRA, POURNASR, BEHSHAD, VOSOUGH, MASSOUD, & NASSIRI ASL, MARJAN. (2017). IN VITRO GENERATED HEPATOCYTE-LIKE CELLS: A NOVEL TOOL IN REGENERATIVE MEDICINE AND DRUG DISCOVERY (REVIEW ARTICLE). CELL JOURNAL (YAKHTEH), 19(2), 204-217. SID. https://sid.ir/paper/688790/en

    Vancouver: Copy

    ZAKIKHAN KOBRA, POURNASR BEHSHAD, VOSOUGH MASSOUD, NASSIRI ASL MARJAN. IN VITRO GENERATED HEPATOCYTE-LIKE CELLS: A NOVEL TOOL IN REGENERATIVE MEDICINE AND DRUG DISCOVERY (REVIEW ARTICLE). CELL JOURNAL (YAKHTEH)[Internet]. 2017;19(2):204-217. Available from: https://sid.ir/paper/688790/en

    IEEE: Copy

    KOBRA ZAKIKHAN, BEHSHAD POURNASR, MASSOUD VOSOUGH, and MARJAN NASSIRI ASL, “IN VITRO GENERATED HEPATOCYTE-LIKE CELLS: A NOVEL TOOL IN REGENERATIVE MEDICINE AND DRUG DISCOVERY (REVIEW ARTICLE),” CELL JOURNAL (YAKHTEH), vol. 19, no. 2, pp. 204–217, 2017, [Online]. Available: https://sid.ir/paper/688790/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top